WeightWatchers launches program for weight-loss drug users
WeightWatchers program aims to help members maintain healthy habits while taking anti-obesity drugs like Ozempic and Wegovy.
Watch CBS News
WeightWatchers program aims to help members maintain healthy habits while taking anti-obesity drugs like Ozempic and Wegovy.
The medication, tirzepatide, was previously approved as Mounjaro for diabetes and will now be marketed as Zepbound for weight loss.
It is unclear if the counterfeit drugs, which many people seek for weight loss, caused the hospitalizations.
The warning about scams comes as sales have boomed for Ozempic, Wegovy and other drugs used for weight loss.
The FDA stopped short of saying the potentially life-threatening condition was caused by the drugs, which have become popular for weight loss.
